Home/NED Biosystems/Brian Leyland-Jones, BSc, MB BS, PhD, FRACP, FRCPC
BL

Brian Leyland-Jones, BSc, MB BS, PhD, FRACP, FRCPC

Chair, Scientific Advisory Board - Oncology

NED Biosystems

NED Biosystems Pipeline

DrugIndicationPhase
NED-170Cancer (specific types not fully specified)Phase 1
NED-260Broad-spectrum antiviralPre-clinical